Related Experiment Video
Updated: Jun 17, 2025

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
A defective splicing machinery promotes senescence through MDM4 alternative splicing
Mathieu Deschênes1, Mathieu Durand1, Marc-Alexandre Olivier2,3
1Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
Abstract:
Defects in the splicing machinery are implicated in various diseases, including cancer. We observed a general reduction in the expression of spliceosome components and splicing regulators in human cell lines undergoing replicative, stress-induced, and telomere uncapping-induced senescence. Supporting the view that defective splicing contributes to senescence, splicing inhibitors herboxidiene, and pladienolide B induced senescence in normal and cancer cell lines. Furthermore, depleting individual spliceosome components also promoted senescence. All senescence types were associated with an alternative splicing transition from the MDM4-FL variant to MDM4-S. The MDM4 splicing shift was reproduced when splicing was inhibited, and spliceosome components were depleted. While decreasing the level of endogenous MDM4 promoted senescence and cell survival independently of the MDM4-S expression status, cell survival was also improved by increasing MDM4-S. Overall, our work establishes that splicing defects modulate the alternative splicing of MDM4 to promote senescence and cell survival.
Insights
Splicing defects reduce spliceosome components, triggering cellular senescence. This process alters MDM4 splicing, promoting both senescence and cell survival, impacting diseases like cancer.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Defects in the splicing machinery are linked to various diseases, including cancer.
- Cellular senescence is a state of irreversible growth arrest with implications in aging and disease.
Purpose of the Study:
- To investigate the role of splicing defects in cellular senescence.
- To explore the impact of spliceosome component reduction and splicing inhibition on senescence.
- To determine the specific alternative splicing events associated with senescence and their effect on cell survival.
Main Methods:
- Analysis of spliceosome component expression in senescent human cell lines.
- Induction of senescence using splicing inhibitors (herboxidiene, pladienolide B) and depletion of spliceosome components.
- Investigation of alternative splicing of the MDM4 gene (MDM4-FL and MDM4-S variants).
- Assessment of cell survival under varying MDM4 levels and MDM4-S expression.
Main Results:
- A general reduction in spliceosome components and splicing regulators was observed in replicative, stress-induced, and telomere uncapping-induced senescence.
- Splicing inhibitors and depletion of spliceosome components induced senescence in normal and cancer cells.
- All senescence types exhibited a shift in MDM4 alternative splicing from the full-length (MDM4-FL) to the short (MDM4-S) variant.
- Decreasing endogenous MDM4 promoted senescence and cell survival, while increasing MDM4-S also improved cell survival.
Conclusions:
- Splicing defects are a significant factor in promoting cellular senescence.
- The alternative splicing of MDM4 is modulated by splicing defects, contributing to senescence and cell survival.
- Targeting splicing pathways may offer therapeutic strategies for diseases associated with senescence and cancer.
Related Concept Videos
RNA Splicing
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Abnormal Proliferation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Nuclear Export of mRNA

